1
Clinical Trials associated with Meningococcal (groups A, C, W-135, and Y) conjugate vaccine(EyeGene)Multicenter, Randomized, Subject/Evaluator Blind, Active Control, Phase II/III Clinical Trial to Assess Immunogenicity and Safety of EG-MCV4 Meningococcal (Groups A, C, W-135, and Y) Conjugated Vaccines
Phase 2/3 study to evaluate immunogenicity and safety in healthy adult participants following a single dose administration of Meningococcal (groups A, C, W-135, and Y) conjugate vaccine
100 Clinical Results associated with Meningococcal (groups A, C, W-135, and Y) conjugate vaccine(EyeGene)
100 Translational Medicine associated with Meningococcal (groups A, C, W-135, and Y) conjugate vaccine(EyeGene)
100 Patents (Medical) associated with Meningococcal (groups A, C, W-135, and Y) conjugate vaccine(EyeGene)
100 Deals associated with Meningococcal (groups A, C, W-135, and Y) conjugate vaccine(EyeGene)